Enzo Short Long Term Debt Total vs Non Currrent Assets Other Analysis

ENZ Stock

USD 1.07 0.02 1.90%

Enzo Biochem financial indicator trend analysis is much more than just examining Enzo Biochem latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Enzo Biochem is a good investment. Please check the relationship between Enzo Biochem Short Long Term Debt Total and its Non Currrent Assets Other accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.

Short Long Term Debt Total vs Non Currrent Assets Other

Short Long Term Debt Total vs Non Currrent Assets Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Enzo Biochem Short Long Term Debt Total account and Non Currrent Assets Other. At this time, the significance of the direction appears to have strong relationship.

The correlation between Enzo Biochem's Short Long Term Debt Total and Non Currrent Assets Other is 0.78. Overlapping area represents the amount of variation of Short Long Term Debt Total that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of Enzo Biochem, assuming nothing else is changed. The correlation between historical values of Enzo Biochem's Short Long Term Debt Total and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt Total of Enzo Biochem are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Short Long Term Debt Total i.e., Enzo Biochem's Short Long Term Debt Total and Non Currrent Assets Other go up and down completely randomly.

Correlation Coefficient

0.78

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Short Long Term Debt Total

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Most indicators from Enzo Biochem's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Enzo Biochem current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.At this time, Enzo Biochem's Selling General Administrative is fairly stable compared to the past year. Discontinued Operations is likely to rise to about 54.7 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.59 in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	42.0M	11.6M	13.3M	12.6M
Total Revenue	107.1M	31.1M	35.7M	63.8M

Gross Profit Total Revenue

Enzo Biochem fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Accounts Payable	Short Term Debt	Common Stock Total Equity	Common Stock
Total Assets		-0.02	0.42	0.5	0.84	0.48	-0.61	-0.12	0.71	0.2	-0.11	0.79	-0.33	0.6	-0.06	0.16	0.29	0.41	0.3	0.51	0.93	-0.44	-0.16	0.09	0.6	0.62
Short Long Term Debt Total	-0.02		-0.21	-0.29	-0.46	0.4	0.54	0.63	-0.12	0.4	0.78	-0.07	-0.59	-0.53	0.98	-0.17	0.21	-0.62	0.8	0.22	-0.16	-0.44	-0.51	0.31	-0.56	-0.55
Other Current Liab	0.42	-0.21		0.85	0.31	0.28	-0.36	-0.27	0.48	0.3	-0.24	0.5	-0.5	0.33	-0.28	0.22	0.2	0.26	0.31	0.61	0.32	0.32	-0.36	0.23	0.41	0.44
Total Current Liabilities	0.5	-0.29	0.85		0.39	0.36	-0.4	-0.49	0.48	0.36	-0.48	0.5	-0.24	0.53	-0.42	0.25	0.22	0.45	0.32	0.63	0.37	0.28	-0.15	0.46	0.62	0.64
Total Stockholder Equity	0.84	-0.46	0.31	0.39		0.14	-0.81	-0.3	0.69	-0.07	-0.38	0.74	0.03	0.65	-0.46	0.11	0.12	0.53	-0.21	0.22	0.88	-0.31	0.17	-0.2	0.66	0.67
Property Plant And Equipment Net	0.48	0.4	0.28	0.36	0.14		0.31	-0.37	-0.11	0.91	-0.15	0.01	-0.17	0.46	0.26	0.68	0.87	0.38	0.62	0.8	0.14	-0.28	0.06	0.65	0.46	0.46
Net Debt	-0.61	0.54	-0.36	-0.4	-0.81	0.31		0.07	-0.87	0.48	0.22	-0.81	0.12	-0.35	0.5	0.31	0.33	-0.25	0.27	0.02	-0.79	0.06	0.11	0.32	-0.38	-0.4
Retained Earnings	-0.12	0.63	-0.27	-0.49	-0.3	-0.37	0.07		0.23	-0.36	0.94	0.22	-0.61	-0.82	0.75	-0.71	-0.45	-0.9	0.31	-0.29	0.01	-0.29	-0.69	-0.39	-0.83	-0.82
Cash	0.71	-0.12	0.48	0.48	0.69	-0.11	-0.87	0.23		-0.26	0.12	0.97	-0.52	0.13	-0.1	-0.43	-0.23	-0.05	0.17	0.21	0.81	-0.22	-0.45	-0.17	0.18	0.21
Non Current Assets Total	0.2	0.4	0.3	0.36	-0.07	0.91	0.48	-0.36	-0.26		-0.17	-0.15	-0.12	0.26	0.25	0.64	0.83	0.23	0.59	0.75	-0.16	-0.09	0.11	0.73	0.29	0.28
Non Currrent Assets Other	-0.11	0.78	-0.24	-0.48	-0.38	-0.15	0.22	0.94	0.12	-0.17		0.13	-0.68	-0.77	0.88	-0.55	-0.26	-0.86	0.49	-0.12	-0.04	-0.37	-0.75	-0.27	-0.79	-0.77
Cash And Short Term Investments	0.79	-0.07	0.5	0.5	0.74	0.01	-0.81	0.22	0.97	-0.15	0.13		-0.55	0.17	-0.05	-0.35	-0.15	-0.02	0.25	0.27	0.85	-0.33	-0.46	-0.16	0.22	0.26
Net Receivables	-0.33	-0.59	-0.5	-0.24	0.03	-0.17	0.12	-0.61	-0.52	-0.12	-0.68	-0.55		0.38	-0.59	0.34	0.08	0.52	-0.74	-0.36	-0.29	0.16	0.91	-0.07	0.35	0.31
Common Stock Shares Outstanding	0.6	-0.53	0.33	0.53	0.65	0.46	-0.35	-0.82	0.13	0.26	-0.77	0.17	0.38		-0.62	0.65	0.45	0.97	-0.18	0.4	0.51	0.0	0.47	0.24	0.99	0.99
Non Current Liabilities Total	-0.06	0.98	-0.28	-0.42	-0.46	0.26	0.5	0.75	-0.1	0.25	0.88	-0.05	-0.59	-0.62		-0.25	0.11	-0.72	0.71	0.12	-0.15	-0.46	-0.56	0.11	-0.65	-0.64
Inventory	0.16	-0.17	0.22	0.25	0.11	0.68	0.31	-0.71	-0.43	0.64	-0.55	-0.35	0.34	0.65	-0.25		0.82	0.68	0.01	0.6	-0.08	0.21	0.46	0.27	0.63	0.62
Other Current Assets	0.29	0.21	0.2	0.22	0.12	0.87	0.33	-0.45	-0.23	0.83	-0.26	-0.15	0.08	0.45	0.11	0.82		0.39	0.35	0.79	-0.02	-0.14	0.3	0.43	0.45	0.44
Other Stockholder Equity	0.41	-0.62	0.26	0.45	0.53	0.38	-0.25	-0.9	-0.05	0.23	-0.86	-0.02	0.52	0.97	-0.72	0.68	0.39		-0.33	0.27	0.33	0.15	0.6	0.26	0.95	0.94
Total Liab	0.3	0.8	0.31	0.32	-0.21	0.62	0.27	0.31	0.17	0.59	0.49	0.25	-0.74	-0.18	0.71	0.01	0.35	-0.33		0.61	0.09	-0.27	-0.62	0.55	-0.16	-0.14
Property Plant And Equipment Gross	0.51	0.22	0.61	0.63	0.22	0.8	0.02	-0.29	0.21	0.75	-0.12	0.27	-0.36	0.4	0.12	0.6	0.79	0.27	0.61		0.23	0.05	-0.19	0.44	0.44	0.46
Total Current Assets	0.93	-0.16	0.32	0.37	0.88	0.14	-0.79	0.01	0.81	-0.16	-0.04	0.85	-0.29	0.51	-0.15	-0.08	-0.02	0.33	0.09	0.23		-0.41	-0.2	-0.17	0.5	0.52
Intangible Assets	-0.44	-0.44	0.32	0.28	-0.31	-0.28	0.06	-0.29	-0.22	-0.09	-0.37	-0.33	0.16	0.0	-0.46	0.21	-0.14	0.15	-0.27	0.05	-0.41		0.04	0.05	0.02	0.03
Accounts Payable	-0.16	-0.51	-0.36	-0.15	0.17	0.06	0.11	-0.69	-0.45	0.11	-0.75	-0.46	0.91	0.47	-0.56	0.46	0.3	0.6	-0.62	-0.19	-0.2	0.04		0.1	0.44	0.4
Short Term Debt	0.09	0.31	0.23	0.46	-0.2	0.65	0.32	-0.39	-0.17	0.73	-0.27	-0.16	-0.07	0.24	0.11	0.27	0.43	0.26	0.55	0.44	-0.17	0.05	0.1		0.26	0.25
Common Stock Total Equity	0.6	-0.56	0.41	0.62	0.66	0.46	-0.38	-0.83	0.18	0.29	-0.79	0.22	0.35	0.99	-0.65	0.63	0.45	0.95	-0.16	0.44	0.5	0.02	0.44	0.26		1.0
Common Stock	0.62	-0.55	0.44	0.64	0.67	0.46	-0.4	-0.82	0.21	0.28	-0.77	0.26	0.31	0.99	-0.64	0.62	0.44	0.94	-0.14	0.46	0.52	0.03	0.4	0.25	1.0

Click cells to compare fundamentals

Enzo Biochem Account Relationship Matchups

Enzo Biochem fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	112.5M	113.7M	95.9M	121.9M	140.2M	100.7M
Short Long Term Debt Total	32.8M	22.7M	20.6M	7.0M	6.3M	6.0M
Other Current Liab	10.3M	11.6M	12.3M	21.1M	24.3M	25.5M
Total Current Liabilities	32.8M	26.1M	24.6M	40.0M	46.0M	48.3M
Total Stockholder Equity	58.4M	68.6M	54.5M	78.5M	90.2M	75.1M
Property Plant And Equipment Net	34.4M	33.6M	32.4M	16.7M	19.2M	12.3M
Net Debt	(15.1M)	9.2M	(1.0M)	(75.4M)	(67.8M)	(64.4M)
Retained Earnings	(278.3M)	(270.4M)	(288.6M)	(268.4M)	(241.5M)	(229.4M)
Cash	47.9M	13.5M	21.6M	82.4M	94.7M	99.5M
Non Current Assets Total	43.8M	43.1M	41.5M	23.4M	26.9M	32.4M
Non Currrent Assets Other	1.4M	1.8M	1.6M	1.7M	1.5M	1.5M
Cash And Short Term Investments	47.9M	43.5M	21.6M	82.4M	94.7M	99.5M
Net Receivables	9.1M	10.2M	11.5M	4.8M	5.5M	5.3M
Common Stock Shares Outstanding	47.7M	48.3M	48.6M	49.2M	56.5M	36.9M
Liabilities And Stockholders Equity	112.5M	113.7M	95.9M	121.9M	140.2M	100.7M
Non Current Liabilities Total	21.4M	19.0M	16.8M	3.4M	3.1M	2.9M
Inventory	7.8M	12.7M	15.4M	7.9M	9.1M	5.6M
Other Current Assets	4.0M	4.2M	5.8M	2.3M	2.7M	2.8M
Other Stockholder Equity	334.5M	337.1M	339.5M	344.4M	396.1M	215.7M
Total Liab	54.2M	45.1M	41.4M	43.4M	39.1M	41.0M
Property Plant And Equipment Gross	34.4M	33.6M	63.9M	34.0M	39.1M	41.0M
Total Current Assets	68.8M	70.6M	54.4M	98.5M	113.2M	68.3M
Accumulated Other Comprehensive Income	1.7M	1.4M	3.2M	1.9M	2.2M	2.3M
Intangible Assets	1.0M	538K	244K	7.5M	6.7M	6.7M
Accounts Payable	8.5M	8.1M	8.5M	3.6M	4.1M	5.0M
Short Term Debt	11.5M	3.7M	3.7M	3.6M	3.2M	3.5M
Common Stock Total Equity	476K	479K	485K	487K	560.1K	422.6K
Common Stock	479K	485K	487K	499K	573.9K	427.7K
Other Assets	1.4M	1.8M	1.6M	6.7M	6.0M	6.3M
Property Plant Equipment	14.5M	33.6M	17.3M	16.7M	19.2M	10.2M
Current Deferred Revenue	(391K)	2.5M	2.7M	11.7M	13.5M	14.2M
Long Term Debt	4.5M	4.4M	4.1M	269K	309.4K	293.9K
Net Tangible Assets	50.4M	60.9M	47.0M	78.5M	90.2M	58.6M
Retained Earnings Total Equity	(252.2M)	(249.7M)	(278.3M)	(288.6M)	(259.8M)	(272.8M)
Capital Surpluse	334.5M	337.1M	339.5M	344.4M	396.1M	359.7M
Non Current Liabilities Other	424K	16.9M	5K	12.8M	14.7M	15.4M
Short Long Term Debt	7.1M	152K	229K	2.6M	2.3M	1.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
GM	General Motors
CRM	Salesforce

When determining whether Enzo Biochem offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enzo Biochem's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enzo Biochem Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enzo Biochem Stock:

How To Invest In Enzo

Details

Is Enzo Stock a good investment?

Details

What is Enzo Biochem's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.

You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Enzo Stock analysis

When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.

	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	CEOs Directory Screen CEOs from public companies around the world
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities

Is Enzo Biochem's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enzo Biochem. If investors know Enzo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enzo Biochem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.47)

Revenue Per Share

0.657

Quarterly Revenue Growth

0.138

Return On Assets

(0.17)

Return On Equity

(0.45)

The market value of Enzo Biochem is measured differently than its book value, which is the value of Enzo that is recorded on the company's balance sheet. Investors also form their own opinion of Enzo Biochem's value that differs from its market value or its book value, called intrinsic value, which is Enzo Biochem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enzo Biochem's market value can be influenced by many factors that don't directly affect Enzo Biochem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Enzo Biochem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enzo Biochem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enzo Biochem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Enzo Short Long Term Debt Total vs Non Currrent Assets Other Analysis

Short Long Term Debt Total vs Non Currrent Assets Other

Short Long Term Debt Total vs Non Currrent Assets Other Correlation Analysis

Correlation Coefficient

Short Long Term Debt Total

Non Currrent Assets Other

Enzo Biochem fundamental ratios Correlations

Enzo Biochem Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Enzo Biochem fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Enzo Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Common Stock Total Equity
Common Stock Total Equity	+ 0.99	Common Stock Shares Outstanding
Common Stock	+ 0.99	Common Stock Shares Outstanding
Non Current Liabilities Total	+ 0.98	Short Long Term Debt Total
Cash And Short Term Investments	+ 0.97	Cash
Other Stockholder Equity	+ 0.97	Common Stock Shares Outstanding

Other Stockholder Equity	- 0.9	Retained Earnings
Cash	- 0.87	Net Debt
Other Stockholder Equity	- 0.86	Non Currrent Assets Other
Common Stock Total Equity	- 0.83	Retained Earnings
Common Stock	- 0.82	Retained Earnings
Common Stock Shares Outstanding	- 0.82	Retained Earnings